Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
100%(3 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
3
50%
Ph phase_3
2
33%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Active, not recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (60.0%)
Phase 32 (40.0%)

Trials by Status

completed350%
active_not_recruiting117%
unknown117%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_2

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

NCT04577352
unknown

Vatiquinone Expanded Access Protocol

NCT07159139
terminatedphase_2

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

NCT04378075
completedphase_3

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655
active_not_recruitingphase_3

A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

NCT05515536
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04577352Phase 2

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

Completed
NCT07159139

Vatiquinone Expanded Access Protocol

Unknown
NCT04378075Phase 2

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Terminated
NCT05218655Phase 3

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Completed
NCT05515536Phase 3

A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

Active Not Recruiting
NCT05485987Phase 2

A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6